Skip to content
JoelGalvan

JoelGalvan

View Video Stories
  • Home
  • Business
  • Culture
  • Sports
  • Home
  • Business
  • Culture
  • Sports
© https://joelgalvan.site/-All rights reserved. Theme Blognest designed by WPInterface.
  • Home
  • Laboratories

Tag: Laboratories

Dr. Reddy’s Laboratories Q1 Results: PAT rises 2% YoY to Rs 1,418 crore, revenue jumps 11%
Posted in Business

Dr. Reddy’s Laboratories Q1 Results: PAT rises 2% YoY to Rs 1,418 crore, revenue jumps 11%

Estimated read time 3 min read
Posted on July 23, 2025
by Joelgalvan

Pharma major Dr. Reddy’s Laboratories reported a marginal 2% year-on-year (YoY) growth in its consolidated net profit at Rs 1,418…

Learn More Leave a Comment on Dr. Reddy’s Laboratories Q1 Results: PAT rises 2% YoY to Rs 1,418 crore, revenue jumps 11%
Charles River Laboratories International (CRL) is Expected to Gain as Industry Growth Resumes
Posted in Business

Charles River Laboratories International (CRL) is Expected to Gain as Industry Growth Resumes

Estimated read time 3 min read
Posted on July 16, 2025
by Joelgalvan

Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” Q2 2025 investor letter. A copy of the…

Learn More Leave a Comment on Charles River Laboratories International (CRL) is Expected to Gain as Industry Growth Resumes
Neuland Laboratories shares jump 12% ahead of final dividend
Posted in Business

Neuland Laboratories shares jump 12% ahead of final dividend

Estimated read time 2 min read
Posted on July 14, 2025
by Joelgalvan

Shares of Neuland Laboratories are trading sharply higher on Monday, up 12% at Rs 13,750 amid strong buying interest. Investors…

Learn More Leave a Comment on Neuland Laboratories shares jump 12% ahead of final dividend
Dr. Reddy’s Laboratories shares to go ex-dividend tomorrow. Do you own?
Posted in Business

Dr. Reddy’s Laboratories shares to go ex-dividend tomorrow. Do you own?

Estimated read time 2 min read
Posted on July 9, 2025
by Joelgalvan

Shares of Dr Reddy’s Laboratories are in focus on Wednesday, July 9, as today marks the last trading day for…

Learn More Leave a Comment on Dr. Reddy’s Laboratories shares to go ex-dividend tomorrow. Do you own?
Is Charles River Laboratories Stock Underperforming the S&P 500?
Posted in Business

Is Charles River Laboratories Stock Underperforming the S&P 500?

Estimated read time 2 min read
Posted on June 27, 2025
by Joelgalvan

Charles River Laboratories International Inc_ logo- by IgorGolovniov via Shutterstock Valued at a market cap of $7.3 billion, Charles River…

Learn More Leave a Comment on Is Charles River Laboratories Stock Underperforming the S&P 500?
Postcolonial laboratories | Eurozine
Posted in Culture

Postcolonial laboratories | Eurozine

Estimated read time 20 min read
Posted on June 18, 2025
by Joelgalvan

I was at a Holiday Inn just off a Los Angeles highway when the Gulf War started. We were on…

Learn More Leave a Comment on Postcolonial laboratories | Eurozine
Alkem Laboratories shares drop 5% after Q4 results. Should you buy, sell, or hold?
Posted in Business

Alkem Laboratories shares drop 5% after Q4 results. Should you buy, sell, or hold?

Estimated read time 2 min read
Posted on May 30, 2025
by Joelgalvan

Alkem Laboratories shares declined 5% to Rs 5,025 in Friday’s intraday trade on the BSE after the company reported a…

Learn More Leave a Comment on Alkem Laboratories shares drop 5% after Q4 results. Should you buy, sell, or hold?
Benchmark Reiterates Buy Rating on Silicon Laboratories (SLAB) Stock, Keeps PT at $160
Posted in Business

Benchmark Reiterates Buy Rating on Silicon Laboratories (SLAB) Stock, Keeps PT at $160

Estimated read time 2 min read
Posted on May 24, 2025
by Joelgalvan

On May 21, Benchmark reiterated its Buy rating on Silicon Laboratories Inc. (NASDAQ:SLAB) stock, keeping the price target at $160.…

Learn More Leave a Comment on Benchmark Reiterates Buy Rating on Silicon Laboratories (SLAB) Stock, Keeps PT at $160
Divi’s Laboratories Q4 results: PAT surges 26% YoY, revenue up 12%
Posted in Business

Divi’s Laboratories Q4 results: PAT surges 26% YoY, revenue up 12%

Estimated read time 2 min read
Posted on May 17, 2025
by Joelgalvan

Divi’s Laboratories on Saturday announced their results for the March quarter of the financial year 2025, reporting a 25.6% year-on-year…

Learn More Leave a Comment on Divi’s Laboratories Q4 results: PAT surges 26% YoY, revenue up 12%

Recent Posts

  • Josh Allen, Bills welcome being under the ‘Hard Knocks’ spotlight at training camp
  • Ganuelas-Rosser answers the call as TNT stays alive
  • Analysts Trim Price Targets but See Long-Term Value in UnitedHealth (UNH)
  • Historic loss a big moment in Cardinals’ deadline decisions
  • Reserve Bank of India: India’s economy shows resilience amid global tariff challenges, macroeconomic risks

Recent Comments

No comments to show.

Archives

  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025

Categories

  • Business
  • Culture
  • Sports
© https://joelgalvan.site/-All rights reserved. Theme Blognest designed by WPInterface.